Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWHIreland Regulatory News (WHI)

  • This share is currently suspended. It was suspended at a price of 3.75
  • There is currently no data for WHI

Director/PDMR Shareholding

29 Oct 2013 07:00

RNS Number : 5842R
W.H. Ireland Group PLC
29 October 2013
 



WH Ireland Group plc

 

("WH Ireland" or the "Company")

 

Director's dealing

 

WH Ireland announces that on 28 October 2013, Richard Killingbeck, Chief Executive Officer of the Company, and the WH Ireland Group plc Employee Share Ownership Trust ("ESOT") entered into a joint share ownership agreement ("JSOA") in relation to 1,000,000 ordinary shares of 5p each in the Company ("JSOA Shares").

 

Under the terms of the JSOA, Richard Killingbeck has an option to acquire the ESOT's interest in the JSOA Shares at a maximum price of £0.745 per Share (the "Exercise Price") at any time between 28 October 2016 and 28 October 2023. The Exercise Price is subject to a formula based on a total return to WH Ireland shareholders over a 3 year period. It is dependent on the mid-market price of an ordinary share of 5p in the Company (an "Ordinary Share") on 28 October 2016 together with the aggregate dividends paid on an Ordinary Share over the preceding 3 year period (the "3 Year Value"). The main terms of the formula are that, in the event that the 3 Year Value is:

 

· less than or equal to £1.15, the Exercise Price will be £0.745

· £2.00 or more, the Exercise Price will be nil; and

· between £1.15 and £2.00 the Exercise Price will decrease on a sliding scale from £0.745 to nil.

 

This arrangement replaces a binding commitment that WH Ireland entered into with Mr Killingbeck prior to his appointment as Chief Executive Officer of the Company, entitling him to be granted an option over 473,787 Ordinary Shares, the terms of which were contained in an announcement made by the Company on 12 November 2012.

 

Following entering into the JSOA, Mr. Killingbeck will hold the following interests in the share capital of the Company:

 

Number of Shares

Percentage of voting rights

Nature of holding

805,000

3.40%

Beneficial

1,000,000

n/a

Held jointly with the ESOT

19,565

n/a

SAYE Scheme*

 

* Under the WH Ireland Save As You Earn Scheme (SAYE), assuming Mr Killingbeck continues to contribute at the full amount defined in his savings contract, this is the maximum number of Ordinary Shares that Mr Killingbeck will have an option to acquire under the terms of the SAYE.

 

For further information please contact:

WH Ireland Group plc

+44 (0) 20 7220 1666

Rupert Lowe, Chairman

Richard Killingbeck, CEO

Panmure Gordon (UK) Limited

+44 (0)20 7886 2500

Hugh Morgan (Corporate Finance)

Adam Pollock (Corporate Broking)

Abchurch Communications

+44 (0)20 7398 7718

Harriet Rae/Joanne Shears/Julian Bosdet

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFSAISLTFIV
Date   Source Headline
25th Mar 20267:00 amRNSCancellation - W.H. Ireland Group Plc
24th Mar 20263:10 pmRNSDisclosure Table
24th Mar 20263:00 pmRNSScheme Becomes Effective
24th Mar 20267:30 amRNSSuspension - W.H. Ireland Group PLC
23rd Mar 20264:02 pmRNSHolding(s) in Company
20th Mar 20263:23 pmRNSISSUE OF EQUITY, PDMR AND RULE 2.9 ANNOUNCEMENT
20th Mar 202612:20 pmRNSCourt Sanction of Scheme of Arrangement
17th Mar 20266:00 pmRNSFTSE Russell Index Changes
6th Mar 20263:00 pmRNSScheme Update – Satisfaction of the FCA Condition
6th Mar 20268:56 amBUSForm 8.5 (EPT/RI) - W.H.Ireland Group
23rd Feb 20264:06 pmRNSWealth Management Custodial Services
23rd Feb 202612:00 pmRNSForm 8.3 - W.H. Ireland Group plc
9th Feb 202610:59 amRNSForm 8.3 - W.H. Ireland Group plc
2nd Feb 202612:53 pmRNSHolding(s) in Company
2nd Feb 202612:28 pmRNSForm 8.3 - W.H. Ireland Group plc
13th Jan 20262:22 pmRNSForm 8.3 - W.H. Ireland Group plc
12th Jan 20269:36 amGNWForm 8.5 (EPT/RI) - W.H. Ireland Group Plc
9th Jan 202610:17 amRNSDirectorate change
8th Jan 202612:50 pmRNSResults of Court Meeting and General Meeting
8th Jan 202611:00 amRNSForm 8.3 - W.H. Ireland Group plc
6th Jan 202611:48 amRNSHolding(s) in Company
30th Dec 202510:08 amGNWForm 8.5 (EPT/RI) - W.H. Ireland Group Plc
29th Dec 20255:48 pmRNSTeam Shareholder Approval Condition Satisfaction
29th Dec 20255:48 pmRNSTeam Shareholder Approval Condition Satisfaction
29th Dec 202510:15 amRNSForm 8.3 - WH Ireland Group plc
24th Dec 202510:16 amBUSForm 8.5 (EPT/RI) - W.H. Ireland Group Plc
24th Dec 202510:16 amGNWForm 8.5 (EPT/RI) - W.H. Ireland Group Plc
19th Dec 20255:26 pmRNSInterim Results
19th Dec 20255:26 pmRNSInterim Results
18th Dec 202511:04 amGNWForm 8.5 (EPT/RI) - W.H.Ireland Group
16th Dec 20259:50 amRNSForm 8.3 - WH Ireland Group PLC
12th Dec 20255:13 pmRNSCorrection of Scheme Document
11th Dec 202510:14 amGNWForm 8.5 (EPT/RI) - W.H.Ireland Group
10th Dec 20254:30 pmRNSPosting of Team Circular and notice of Team EGM
10th Dec 20254:08 pmRNSPublication of Scheme Document and Trading Update
10th Dec 202511:26 amRNSForm 8.3 - WH Ireland Group PLC
10th Dec 202511:24 amRNSForm 8.3 - WH Ireland Group PLC
9th Dec 20252:30 pmRNSForm 8.3 - Team PLC
9th Dec 20252:25 pmRNSForm 8.3 - TEAM PLC
28th Nov 202512:44 pmRNSForm 8.3 - WH Ireland Group PLC
27th Nov 202512:12 pmRNSForm 8.3 - W.H. Ireland Group PLC
27th Nov 20257:30 amRNSRECOMMENDED ACQUISITION OF W.H. IRELAND GROUP PLC
26th Nov 20254:38 pmRNSCorrection: Form 8.3
26th Nov 20253:08 pmRNSForm 8.3
26th Nov 20251:56 pmRNSForm 8.3 - WH Ireland Group PLC
26th Nov 20251:56 pmRNSForm 8.3 - WH Ireland Group PLC
26th Nov 20251:56 pmRNSForm 8.3 - WH Ireland Group PLC
26th Nov 202512:47 pmRNSForm 8 - WH Ireland Group plc
26th Nov 202510:17 amGNWForm 8.5 (EPT/RI) - W.H.Ireland Group
24th Nov 202511:16 amGNWForm 8.5 (EPT/RI) - W.H.Ireland Group

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.